// company-profile
Arrowhead Pharmaceuticals, Inc. Insider Trading
ARWREvery SEC Form 4 insider trading filing for Arrowhead Pharmaceuticals, Inc. (ARWR) — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC.
curl "https://api.form4api.com/v1/transactions?ticker=ARWR" -H "X-Api-Key: YOUR_API_KEY"// activity-summary
No insider transactions in the last 30 days.
// 90-day insight
Over the last 90 days, Arrowhead Pharmaceuticals, Inc. insiders bought $0 across 1 transaction with no open-market sales.
- Most active insider: Lu Hongbo with 1 transaction totaling $228K.
- Largest single sale: $228K by Lu Hongbo on May 12, 2026.
- 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.
Activity skews bullish — buys outpace sales.
Institutional Ownership
Top 13F-HR holders of Arrowhead Pharmaceuticals, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | Cohen Matthew Gregory | ARWR | Award | 11,882 | $0.00 | $0K |
| May 12, 2026 | Lu Hongbo | ARWR | Sale10b5 | 2,970 | $76.88 | $228K |
| Apr 23, 2026 | Hamilton James C | ARWR | Sale10b5 | 10,000 | $75.00 | $750K |
| Apr 22, 2026 | Apel Daniel Joseph | ARWR | Sale10b5 | 1,157 | $70.45 | $82K |
| Apr 22, 2026 | Apel Daniel Joseph | ARWR | Sale10b5 | 8,730 | $71.92 | $628K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →